Ghent University Academic Bibliography

Advanced

Second-line-Therapie der idiopathisch überaktiven Blase: Sakrale Neuromodulation und Botulinumtoxin A

B Amend, D Castro-Diaz, E Chartier-Kastler, D De Ridder, Karel Everaert UGent, M Spinelli, P van Kereebroeck and KD Sievert (2010) UROLOGE. 49(2). p.245-252
abstract
The syndrome of idiopathic overactive bladder (I-OAB) impairs quality of life for the affected individuals. Conservative treatment options such as antimuscarinics are not always effective, and resulting side effects can lead the patient to stop treatment. In recently years, minimally invasive and reversible sacral neuromodulation and botulinum toxin A have become available. Currently, the approved treatment option for I-OAB that is recommended by the International Consultation on Incontinence is sacral neuromodulation by InterStim therapy. This article gives an overview of the present clinical evidence on the effectiveness and reliability of these two treatment modalities as well as the current significance of sacral neuromodulation and botulinum toxin A for the second-line treatment of adult I-OAB.
Please use this url to cite or link to this publication:
author
organization
alternative title
Second-line therapy of idiopathic detrusor overactivity : sacral neuromodulation and botulinum toxin A
year
type
journalArticle (review)
publication status
published
subject
keyword
Urgency frequency syndrome, Sacral neuromodulation, Idiopathic detrusor overactivity, Botulinum toxin A, Second-line therapy, URINARY URGE INCONTINENCE, NERVE-STIMULATION, SUBUROTHELIAL INJECTION, INTRADETRUSOR INJECTION, PATIENT SATISFACTION, TRACT SYMPTOMS, SINGLE-CENTER, TINED LEAD, BLADDER, EFFICACY
journal title
UROLOGE
Urologe
volume
49
issue
2
pages
245 - 252
Web of Science type
Review
Web of Science id
000274903600013
ISSN
1433-0563
DOI
10.1007/s00120-009-2139-5
language
German
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1097617
handle
http://hdl.handle.net/1854/LU-1097617
date created
2011-01-11 15:27:46
date last changed
2011-02-10 13:16:34
@article{1097617,
  abstract     = {The syndrome of idiopathic overactive bladder (I-OAB) impairs quality of life for the affected individuals. Conservative treatment options such as antimuscarinics are not always effective, and resulting side effects can lead the patient to stop treatment. In recently years, minimally invasive and reversible sacral neuromodulation and botulinum toxin A have become available. Currently, the approved treatment option for I-OAB that is recommended by the International Consultation on Incontinence is sacral neuromodulation by InterStim therapy. This article gives an overview of the present clinical evidence on the effectiveness and reliability of these two treatment modalities as well as the current significance of sacral neuromodulation and botulinum toxin A for the second-line treatment of adult I-OAB.},
  author       = {Amend, B and Castro-Diaz, D and Chartier-Kastler, E and De Ridder, D and Everaert, Karel and Spinelli, M and van Kereebroeck, P and Sievert, KD},
  issn         = {1433-0563},
  journal      = {UROLOGE},
  keyword      = {Urgency frequency syndrome,Sacral neuromodulation,Idiopathic detrusor overactivity,Botulinum toxin A,Second-line therapy,URINARY URGE INCONTINENCE,NERVE-STIMULATION,SUBUROTHELIAL INJECTION,INTRADETRUSOR INJECTION,PATIENT SATISFACTION,TRACT SYMPTOMS,SINGLE-CENTER,TINED LEAD,BLADDER,EFFICACY},
  language     = {ger},
  number       = {2},
  pages        = {245--252},
  title        = {Second-line-Therapie der idiopathisch {\"u}beraktiven Blase: Sakrale Neuromodulation und Botulinumtoxin A},
  url          = {http://dx.doi.org/10.1007/s00120-009-2139-5},
  volume       = {49},
  year         = {2010},
}

Chicago
Amend, B, D Castro-Diaz, E Chartier-Kastler, D De Ridder, Karel Everaert, M Spinelli, P van Kereebroeck, and KD Sievert. 2010. “Second-line-Therapie Der Idiopathisch Überaktiven Blase: Sakrale Neuromodulation Und Botulinumtoxin A.” Urologe 49 (2): 245–252.
APA
Amend, B., Castro-Diaz, D., Chartier-Kastler, E., De Ridder, D., Everaert, K., Spinelli, M., van Kereebroeck, P., et al. (2010). Second-line-Therapie der idiopathisch überaktiven Blase: Sakrale Neuromodulation und Botulinumtoxin A. UROLOGE, 49(2), 245–252.
Vancouver
1.
Amend B, Castro-Diaz D, Chartier-Kastler E, De Ridder D, Everaert K, Spinelli M, et al. Second-line-Therapie der idiopathisch überaktiven Blase: Sakrale Neuromodulation und Botulinumtoxin A. UROLOGE. 2010;49(2):245–52.
MLA
Amend, B, D Castro-Diaz, E Chartier-Kastler, et al. “Second-line-Therapie Der Idiopathisch Überaktiven Blase: Sakrale Neuromodulation Und Botulinumtoxin A.” UROLOGE 49.2 (2010): 245–252. Print.